Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers (original) (raw)
Inhibitory effects of type A and type B monoamine oxidase inhibitors on synaptosomal accumulation of [3H]dopamine: a reflection of antidepressant potency
Albert Azzaro
Biochemical Pharmacology, 1982
View PDFchevron_right
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
Y. Bakhle
British Journal of Pharmacology, 2009
View PDFchevron_right
Preclinical Evaluation of Antidepressant Activity of New Monoamine Oxidase Inhibitors in Rodents
Vijaya Pandit
2016
View PDFchevron_right
Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery
Gary Caldwell
Analytical Biochemistry, 2004
View PDFchevron_right
Design and early clinical evaluation of selective inhibitors of monoamine oxidase
Michael Palfreyman
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
View PDFchevron_right
Investigating the Role of Monoamine Oxidase Inhibitors in the Treatment of Major Depressive Disorder
Cal R Westbury
View PDFchevron_right
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Jean Shih
Advanced Drug Delivery Reviews, 2008
View PDFchevron_right
Depression and monoamine oxidase
Hanfried Helmchen
Progress in Neuro-Psychopharmacology, 1979
View PDFchevron_right
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
John Finberg
Frontiers in Pharmacology, 2016
View PDFchevron_right
Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle
Michael Entzeroth
Open Journal of Depression
View PDFchevron_right
Overview of the CNS pharmacology of BW 1370U87: A chemically novel, reversible, selective MAO-A inhibitor with potential to be a new antidepressant drug
Gary Kraemer
Drug Development Research, 1992
View PDFchevron_right
Antidepressant Like Effect of Newly Synthesized Compound 2[(N- Benzylacetamido) Mercapto] Benzimidazole (VS 25) and Its Possible Mechanism by Inhibition of Monoamine Oxidase Enzyme in Mice
Vaishali Mute
International Journal of Pharmacy and Pharmaceutical Sciences, 2014
View PDFchevron_right
In vivo intraneuronal MAO inhibition in rat brain SKF 64139, comparison to other potent PNMT inhibitors
Ivan Mefford
European Journal of Pharmacology, 1981
View PDFchevron_right
Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential
Simone Carradori, Paola Chimenti
Expert Opinion on Therapeutic Patents, 2012
View PDFchevron_right
Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches
Pablo Duarte
Reactive Oxygen Species, 2020
View PDFchevron_right
Studies on Monoamine Oxidase
Akira Shaki Arai
The Japanese Journal of Pharmacology, 1960
View PDFchevron_right
Selective inhibition of MAO-A activity results in an antidepressant-like action of 2-benzoyl 4-iodoselenophene in mice
Renan Pistoia
Physiology & Behavior, 2017
View PDFchevron_right
Monoamine oxidase a inhibition by fluoxetine: An in vitro and in vivo study
Jogeshwar Mukherjee
Synapse, 1999
View PDFchevron_right
The Effect of the anticonvulsant (S)-2-[4-(3-Flouro-Benzyloxy) Benzylamino]- Propionamide on Monoamine Oxidase (A)
Keith Tipton
Biochemistry Letters, 2016
View PDFchevron_right
Effects of monoamine oxidase a inhibition on plasma biogenic amine metabolites in depressed patients
Manolis Markianos
Psychiatry Research, 1994
View PDFchevron_right
Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase
Anis Mir, Mark Tricklebank
European Journal of Pharmacology, 1986
View PDFchevron_right
Metabolism of monoamine oxidase inhibitors
L. Urichuk
Cellular and molecular neurobiology, 1999
View PDFchevron_right
Chromone2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B
Fernanda yañez
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior
Gerard Marek
Psychopharmacology, 1988
View PDFchevron_right
Half a Century of Antidepressant Drugs
Cecilio Alamo
Journal of Clinical Psychopharmacology, 2008
View PDFchevron_right
Modification of the activity of mitochondrial monoamine oxidasesin vitro andin vivo
Inta Kalnina
Agents and Actions, 1981
View PDFchevron_right
Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells
Ulrich Hemmeter
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
View PDFchevron_right
Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression
Moussa Youdim
Psychopharmacology, 2002
View PDFchevron_right